Korean J Gastroenterol.  2022 Apr;79(4):191-193. 10.4166/kjg.2022.046.

The Efficacy of Gastric Per-oral Endoscopic Myotomy for Refractory Gastroparesis

• Boo SJ

• KMID: 2529371
• DOI: http://doi.org/10.4166/kjg.2022.046

Abstract

Gastric Per-oral Endoscopic Myotomy (G-POEM) for Refractory Gastroparesis: Results from an International Prospective Trial

Reference

1. Jung HK, Choung RS, Locke GR 3rd, et al. 2009; The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 136:1225–1233. DOI: 10.1053/j.gastro.2008.12.047. PMID: 19249393. PMCID: PMC2705939.

2. Aghaie Meybodi M, Qumseya BJ, Shakoor D, et al. 2019; Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open. 7:E322–E329. DOI: 10.1055/a-0812-1458. PMID: 30842971. PMCID: PMC6400657.

3. Spadaccini M, Maselli R, Chandrasekar VT, et al. 2020; Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc. 91:746–752.e5. DOI: 10.1016/j.gie.2019.11.039. PMID: 31809720.

4. Khashab MA, Stein E, Clarke JO, et al. 2013; Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 78:764–768. DOI: 10.1016/j.gie.2013.07.019. PMID: 24120337.

5. Vosoughi K, Ichkhanian Y, Benias P, et al. 2022; Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. 71:25–33. DOI: 10.1136/gutjnl-2020-322756. PMID: 33741641.

6. Khashab MA, Ngamruengphong S, Carr-Locke D, et al. 2017; Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 85:123–128. DOI: 10.1016/j.gie.2016.06.048. PMID: 27354102.

7. Kashyap P, Farrugia G. 2010; Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 59:1716–1726. DOI: 10.1136/gut.2009.199703. PMID: 20871131. PMCID: PMC2996823.

8. Arts J, Holvoet L, Caenepeel P, et al. 2007; Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 26:1251–1258. DOI: 10.1111/j.1365-2036.2007.03467.x. PMID: 17944739.

9. Clarke JO, Sharaiha RZ, Kord Valeshabad A, Lee LA, Kalloo AN, Khashab MA. Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy. 2013; 45 Suppl 2 UCTN:E189–E190. DOI: 10.1055/s-0032-1326400.

10. Gourcerol G, Tissier F, Melchior C, et al. 2015; Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther. 41:360–367. DOI: 10.1111/apt.13053. PMID: 25523288.

11. Mekaroonkamol P, Dacha S, Wang L, et al. 2019; Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis. Clin Gastroenterol Hepatol. 17:82–89. DOI: 10.1016/j.cgh.2018.04.016. PMID: 29660525.

12. Hirsch W, Nee J, Ballou S, et al. 2019; Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013. J Clin Gastroenterol. 53:109–113. DOI: 10.1097/MCG.0000000000000972. PMID: 29256990. PMCID: PMC6005709.

13. Ye Y, Bennett D. 2020; The first national prevalence estimation of gastroparesis in the United States using a large-scale retrospective database. J Clin Gastroenterol. 54:106. DOI: 10.1097/MCG.0000000000001279. PMID: 31702589. PMCID: PMC6903322.

14. Lee KN. 2021; Gastroparesis in Asia: an area still unfamiliar to Asian gastroenterologists. J Neurogastroenterol Motil. 27:5–7. DOI: 10.5056/jnm20255. PMID: 33380551. PMCID: PMC7786089.